Literature DB >> 14623635

Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon.

Stephan Rosenkranz, Frank Diet, Thomas Karasch, Julia Weihrauch, Klaus Wassermann, Erland Erdmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14623635     DOI： 10.7326/0003-4819-139-10-200311180-00030

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  13 in total

1.  Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports.

Authors:  Ikuko Hayakawa; Fumiaki Shirasaki; Takashi Hirano; Naoto Oishi; Minoru Hasegawa; Shinichi Sato; Kazuhiko Takehara
Journal:  Rheumatol Int       Date:  2005-05-25       Impact factor: 2.631

Review 2.  [Medicinal vasoactive therapy of microcirculation disorders in rheumatoid arthritis].

Authors:  G Riemekasten; H Schulze-Koops
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

3.  [Recommendations of the German Society of Rheumatology on therapy of Raynaud syndrome and acral ulcerations].

Authors:  G Riemekasten
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

Review 4.  New lines in therapy of Raynaud's phenomenon.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

5.  [Primary and secondary Raynaud's phenomenon].

Authors:  J H W Distler
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

Review 6.  Advances in the treatment of Raynaud's phenomenon.

Authors:  Terri L Levien
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

7.  Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects.

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Edoardo Rosato; Felice Salsano; Giovanni Spera
Journal:  Int J Rheumatol       Date:  2010-10-05

Review 8.  Pulmonary hypertension caused by sarcoidosis.

Authors:  Enrique Diaz-Guzman; Carol Farver; Joseph Parambil; Daniel A Culver
Journal:  Clin Chest Med       Date:  2008-09       Impact factor: 2.878

9.  Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.

Authors:  Uma Kumar; Gokhale Sankalp; Sankalp S Gokhle; V Sreenivas; Satbir Kaur; Durgaprasanna Misra
Journal:  Rheumatol Int       Date:  2012-07-26       Impact factor: 2.631

Review 10.  Pulmonary hypertension: current diagnosis and treatment.

Authors:  Stephan Rosenkranz
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.